Growth Metrics

CorMedix (CRMD) Cash from Operations (2016 - 2025)

CorMedix has reported Cash from Operations over the past 15 years, most recently at 94461181.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 94461181.0 for Q4 2025, up 1782.34% from a year ago — trailing twelve months through Dec 2025 was 175046000.0 (up 445.84% YoY), and the annual figure for FY2025 was 175046000.0, up 445.84%.
  • Cash from Operations reached 94461181.0 in Q4 2025 per CRMD's latest filing, up from 30856502.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 94461181.0 in Q4 2025 and bottomed at 17310294.0 in Q1 2024.
  • Median Cash from Operations over the past 5 years was 6075137.5 (2022), compared with a mean of 2025478.25.
  • The largest annual shift saw Cash from Operations plummeted 309.81% in 2021 before it surged 1782.34% in 2025.
  • Over 5 years, Cash from Operations stood at 5869360.0 in 2021, then decreased by 4.86% to 6154839.0 in 2022, then plummeted by 74.59% to 10745694.0 in 2023, then surged by 47.75% to 5614883.0 in 2024, then soared by 1782.34% to 94461181.0 in 2025.
  • Business Quant data shows Cash from Operations for CRMD at 94461181.0 in Q4 2025, 30856502.0 in Q3 2025, and 29991814.0 in Q2 2025.